Literature DB >> 24155535

Long term follow-up of intralesional laser photocoagulation (ILP) for hemangioma patients.

Cheng-Jen Chang1.   

Abstract

BACKGROUND AND OBJECTIVES: Hemangiomas remain a challenge for patients and plastic surgeons. Promising results have been reported using intralesional photocoagulation (ILP) for treatment. The objective of our study is to review the long term results of a large series of hemangiomas in patients treated by ILP. Materials (Subjects) and
Methods: A retrospective review of 684 hemangiomas in patients were treated by ILP with an Nd:YAG (neodymium-yttrium-aluminium-garnet) (1064 nm) laser over a period of 10 years (January 1996-January 2005). Patients' ages ranged from one month to 11 years 5 months (mean, 1 year 10 months). The patient group consisted of 474 females and 210 males.
RESULTS: Patients were treated with an Nd:YAG laser delivered through a 600 m optical fiber. Laser power was set at 7 to 15 watts (W) and delivered with pulse duration of 7 to 15 seconds (s). The results showed 603 (88.6%) patients had more than 50% reduction of the volume in hemangiomas at 3 months after one treatment; and 663 (96.9%) patients had more than 50% reduction of the volume at 3 months after two treatments. Patients who had continuous ILP achieved excellent results.
CONCLUSIONS: Postoperative complications have been related to photocoagulation that has been delivered too extensively or superficially, with resultant ulceration, infection, bleeding, and scarring. These complications can be avoided if this potential for harm is kept in mind.

Entities:  

Keywords:  Hemangioma; ILP; Nd:YAG Laser; Vascular malformation; intralesional photocoagulation

Year:  2011        PMID: 24155535      PMCID: PMC3799045          DOI: 10.5978/islsm.11-or-03

Source DB:  PubMed          Journal:  Laser Ther        ISSN: 0898-5901


  36 in total

Review 1.  Lasers in pediatric surgery.

Authors:  H P Berlien; G Müller; J Waldschmidt
Journal:  Prog Pediatr Surg       Date:  1990

2.  Treatment of a capillary hemangioma with the flashlamp pumped-dye laser.

Authors:  K A Sherwood; O T Tan
Journal:  J Am Acad Dermatol       Date:  1990-01       Impact factor: 11.527

3.  Compression treatment of hemangiomas.

Authors:  S H Miller; R L Smith; S J Shochat
Journal:  Plast Reconstr Surg       Date:  1976-11       Impact factor: 4.730

Review 4.  Treatment of hemangiomatosis with recombinant interferon alfa.

Authors:  C W White
Journal:  Semin Hematol       Date:  1990-07       Impact factor: 3.851

5.  Combined treatment of head and neck vascular masses with preoperative embolization.

Authors:  M S Persky; A Berenstein; N L Cohen
Journal:  Laryngoscope       Date:  1984-01       Impact factor: 3.325

6.  Intralesional photocoagulation of vascular anomalies of the tongue.

Authors:  C J Chang; D M Fisher; Y R Chen
Journal:  Br J Plast Surg       Date:  1999-04

7.  Further evaluation of the potential of the argon laser in the treatment of strawberry hemangiomas.

Authors:  L W Hobby
Journal:  Plast Reconstr Surg       Date:  1983-04       Impact factor: 4.730

8.  Strawberry hemangioma of infancy: early definitive treatment with an argon laser.

Authors:  B M Achauer; V M Vander Kam
Journal:  Plast Reconstr Surg       Date:  1991-09       Impact factor: 4.730

9.  Extended use of sodium tetradecyl sulfate in treatment of hemangiomas and other related conditions.

Authors:  J E Woods
Journal:  Plast Reconstr Surg       Date:  1987-04       Impact factor: 4.730

10.  Treatment of cutaneous and deep vascular lesions with the Nd:YAG laser.

Authors:  H Rosenfeld; R Sherman
Journal:  Lasers Surg Med       Date:  1986       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.